Please assess the completion status of the following clinical trial:

Trial Title: Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>18 years.~* A clinical diagnosis of MINOCA within the last 30 days.~* Left ventricular ejection fraction ≥40% measured with echocardiography, MRI or left ventriculography after admission and prior to randomization.~* Written informed consent obtained~Exclusion Criteria:~* Any condition that may influence the patient's ability to comply with study protocol.~* Previous revascularization (CABG or PCI)~* Clinical signs of heart failure~* MRI-proven myocarditis or a strong clinical suspicion of myocarditis or takotsubo as cause of the index event~* Contraindications for Beta blocker treatment~* Contraindications for ACEI and ARB treatment~* Prior use of ACEI, ARB, or Beta blockers, which must continue according to treating physician.~* New indication for Beta blocker or ACEI/ARB treatment other than as secondary prevention according to treating physician~* Ongoing pregnancy or woman of childbearing potential not using adequate contraceptives~* Participation in a trial evaluating a drug known to interact with Beta blockers or ACEI/ARB

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- No Beta blocker and no ACEI/ARB (Type: NO_INTERVENTION): No Beta blocker and no ACEI/ARB
- Beta blocker and ACEI/ARB (Type: EXPERIMENTAL): Beta blocker and either ACE inhibitor or Angiotensin receptor blocker
- Beta blocker alone (Type: EXPERIMENTAL): Beta blocker alone
- ACEI/ARB alone (Type: EXPERIMENTAL): Either ACE inhibitor or Angiotensin receptor blocker alone

Based on this trial design, predict the completion outcome and termination type (if applicable).